Amid a rising uproar over drug prices, UnitedHealthcare said Tuesday it will pass along to consumers in employer-based plans the rebates it receives from pharmaceutical companies.
Amid a rising uproar over drug prices, UnitedHealthcare said Tuesday it will pass along to consumers in employer-based plans the rebates it receives from pharmaceutical companies.
The health insurer, whose parent company owns the pharmacy benefit plan OptumRx, said it will expand pharmacy discounts to millions of its plan participants when they fill prescriptions through retail pharmacies or home delivery. The discounts will apply to over 7 million people enrolled in commercial group benefit plans. Discounts will come at the pharmacy counter at the time of purchase beginning on January 1, 2019.
The savings will apply to plan participants who are filling a prescription for a drug where the manufacturer provides a rebate.
In a statement, HHS Secretary Alex Azar praised the move.
“Today’s announcement by UnitedHealthcare is a prime example of the type of movement toward transparency and lower drug prices for millions of patients that the Trump administration is championing,” Azar said. “Empowering patients and providers with the information and control to put them in the driver’s seat is a key part of our strategy at the Department of Health and Human Services to bring down the price of drugs and make healthcare more affordable. We are already seeing clear momentum toward the type of innovation in the private-sector that will be an important part of the value-based transformation that is coming to America’s healthcare system.”
Dan Schumacher, the president of UnitedHealthcare, told The New York Times that those in plans with high deductibles who buy drugs with large rebates will see the greatest savings.
The Trump administration has previously suggested that the same rebates could be passed on to those in Medicare programs.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More